Skip to main content
. 2020 Jul 17;11:1087. doi: 10.3389/fphar.2020.01087

Figure 1.

Figure 1

Synergistic cytotoxicity of AsIII combined with Tetra in human breast cancer cell lines. Following treatment with various concentrations of AsIII alone (5, 10, and 15 µM), Tetra alone (5.6, 6.4, and 7.2 μM), or their combination for 48 h, the cell viability of MDA-MB-231 (A) and T47D (B) was determined by XTT assay. Relative cell viability was calculated as the ratio of the absorbance at 450 nm of each treatment group against those of the corresponding untreated control group. Data are shown as the means and SD from more than three independent experiments. *p<0.05 vs. control; #p<0.001 vs. each alone. As, AsIII; Tetra, tetrandrine.